Stormont Health Minister Mike Nesbitt has announced a new framework aimed at promoting open communication between patients, families and staff. He said the Being Open Framework comes after several ...
Adding Merck & Co. and Moderna’s vaccine candidate to Keytruda has continued to cut the risk of cancer recurrence or death across five years of follow-up, boosting the companies’ prospects as they ...
This is read by an automated voice. Please report any issues or inconsistencies here. GUATIRE, Venezuela — The United States and Venezuelan governments said Friday that they were exploring the ...
Xi emphasises mutual respect, win-win outcomes with Ireland Xi urges Ireland to aid China-EU relations during EU presidency Ireland acknowledges China's global role, stresses open trade importance ...
The murder of Sharif Osman Bin Hadi, who had participated in the July Uprising, which resulted in the ouster of Prime Minister Sheikh Hasina’s government, has triggered violent chaos in Bangladesh.
Background Recurrent mitral regurgitation (MR) remains a major limitation of mitral valve (MV) repair in patients with ...
A group of civil rights organizations is seeking an order to prevent the closure of a Justice Department office dedicated to preventing unrest and violence in U.S. cities. The groups are suing for a ...
The marketing and communication worlds are transforming rapidly as artificial intelligence (AI) continues to penetrate the mainstream. The most common tactics and strategies for increasing awareness, ...
Weekend mornings anchor, CBS New York; Correspondent, CBS News and Stations Elaine Quijano is a weekend mornings anchor for CBS New York and a correspondent for CBS News and Stations, contributing to ...
White House senior counsel for trade and manufacturing Peter Navarro spoke to the Council on Foreign Relations on Friday morning about the administration's "America First" policy agenda, their general ...
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ:REGN) PD-1 inhibitor Libtayo (cemiplimab-rwlc) as an adjuvant treatment for adult patients ...
Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results